Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Tenocyte Implantation for chronic Achilles tendinopathy
NL-OMON38070Phase 2Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Apr 2011
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of autologous tenocytes in Achilles tendinitis (AT) (2 arms), sponsored by Erasmus MC. Primary endpoint: VISA-A score. Started Apr 2011; status: active, not recruiting.
02
Drugs
autologous tenocytes
03
Conditions
Achilles tendinitis (AT)
Beyond the preview
Go deeper on NL-OMON38070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38070.